Topoisomerase II-mediated cleavage of plasmid DNA.
Burden
D A
DA
Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN, USA.
Froelich-Ammon
S J
SJ
Osheroff
N
N
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology; D004250:DNA Topoisomerases, Type II / Q000378:metabolism*; D004269:DNA, Bacterial / Q000737:chemistry / Q000378:metabolism; D004278:DNA, Superhelical / Q000737:chemistry / Q000378:metabolism; D004331:Drosophila melanogaster / Q000201:enzymology; D004587:Electrophoresis, Agar Gel; D005047:Etoposide / Q000494:pharmacology; D009690:Nucleic Acid Conformation / Q000187:drug effects; D010957:Plasmids / Q000737:chemistry / Q000378:metabolism*; D059005:Topoisomerase II Inhibitors
D000970:Antineoplastic Agents; D004269:DNA, Bacterial; D004278:DNA, Superhelical; D059005:Topoisomerase II Inhibitors; D005047:Etoposide; D004250:DNA Topoisomerases, Type II